Cargando…

Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent® Technology

Detalles Bibliográficos
Autor principal:	Matsushita, Takefumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2011
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208194/ https://www.ncbi.nlm.nih.gov/pubmed/22065966 http://dx.doi.org/10.5045/kjh.2011.46.3.148

Ejemplares similares

Macrophages are critical effectors of antibody therapies for cancer
por: Weiskopf, Kipp, et al.
Publicado: (2015)

Editorial: Effector functions of therapeutic antibodies
por: Boross, Peter, et al.
Publicado: (2023)

Using CRISPR to enhance T cell effector function for therapeutic applications
por: Freen-van Heeren, Julian J.
Publicado: (2020)

Advances in Aptamer-Based Biosensors and Cell-Internalizing SELEX Technology for Diagnostic and Therapeutic Application
por: Gan, Zixuen, et al.
Publicado: (2022)

Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody
por: Zhang, Di, et al.
Publicado: (2016)

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
por: van der Horst, Hilma J., et al.
Publicado: (2020)

Monoclonal Antibodies for Bacterial Pathogens: Mechanisms of Action and Engineering Approaches for Enhanced Effector Functions
por: Vacca, Fabiola, et al.
Publicado: (2022)

Challenges and opportunities for engineering thermochemistry in carbon-neutralization technologies
por: Xu, Guangwen, et al.
Publicado: (2022)

Therapeutic antibodies for infectious diseases
por: Sparrow, Erin, et al.
Publicado: (2017)

Harnessing conserved signaling and metabolic pathways to enhance the maturation of functional engineered tissues
por: Callaghan, Neal I., et al.
Publicado: (2022)

Rethinking the INN system for therapeutic antibodies
por: Pottier, Jérémy, et al.
Publicado: (2016)

IgG Fc engineering to modulate antibody effector functions
por: Wang, Xinhua, et al.
Publicado: (2017)

Asymmetric Fc Engineering for Bispecific Antibodies with Reduced Effector Function
por: Escobar-Cabrera, Eric, et al.
Publicado: (2017)

Engineered Fc-glycosylation switch to eliminate antibody effector function
por: Zhou, Qun, et al.
Publicado: (2020)

Fc-engineered antibodies with immune effector functions completely abolished
por: Wilkinson, Ian, et al.
Publicado: (2021)

LACTB, a Metabolic Therapeutic Target in Clinical Cancer Application
por: Li, Xiaohua, et al.
Publicado: (2022)

Therapeutic index improvement of antibody-drug conjugates
por: Gerber, Hans-Peter, et al.
Publicado: (2023)

Genetically Engineered Cellular Membrane Vesicles as Tailorable Shells for Therapeutics
por: Ren, En, et al.
Publicado: (2021)

Shuffling effector genes through mini-chromosomes
por: Ma, Li-Jun, et al.
Publicado: (2019)

Application of genome engineering for treatment of retinal diseases
por: Jo, Dong Hyun, et al.
Publicado: (2018)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
por: Liu, Rena, et al.
Publicado: (2020)

Application of iron oxide anoparticles in neuronal tissue engineering
por: Ziv-Polat, Ofra, et al.
Publicado: (2015)

Engineering Complexity in Bacterial Regulatory Circuits for Biotechnological Applications
por: Westmann, Cauã Antunes, et al.
Publicado: (2018)

Strategy of injectable hydrogel and its application in tissue engineering
por: Zhu, Wei, et al.
Publicado: (2021)

Enabling functional genomics with genome engineering
por: Hilton, Isaac B., et al.
Publicado: (2015)

Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
por: Sempowski, Gregory D., et al.
Publicado: (2020)

Perspective: The promises of a holistic view of proteins—impact on antibody engineering and drug discovery
por: Phua, Ser-Xian, et al.
Publicado: (2019)

Insidious Insights: Implications of viral vector engineering for pathogen enhancement
por: Sandbrink, Jonas B., et al.
Publicado: (2022)

Regulation of neuroinflammatory properties of glial cells by T cell effector molecules
por: Prajeeth, Chittappen K., et al.
Publicado: (2018)

Paper-Based Molecular-Imprinting Technology and Its Application
por: Xu, Shufang, et al.
Publicado: (2022)

Animal immunization merges with innovative technologies: A new paradigm shift in antibody discovery
por: Prabakaran, Ponraj, et al.
Publicado: (2021)

Engineering nerve guidance conduits with three-dimenisonal bioprinting technology for long gap peripheral nerve regeneration
por: Du, Jian, et al.
Publicado: (2019)

Developing a new class of engineered live bacterial therapeutics to treat human diseases
por: Charbonneau, Mark R., et al.
Publicado: (2020)

Proteomics of Brucella: Technologies and Their Applications for Basic Research and Medical Microbiology
por: Wareth, Gamal, et al.
Publicado: (2020)

3D Printed MEMS Technology—Recent Developments and Applications
por: Blachowicz, Tomasz, et al.
Publicado: (2020)

On the applicability of the ‘humic acids’ nomenclature from natural ecosystems to engineering sciences
por: Zhao, Xinyu, et al.
Publicado: (2021)

Enhancing antibody patent protection using epitope mapping information
por: Deng, Xiaoxiang, et al.
Publicado: (2017)

Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies
por: Halstead, Scott B.
Publicado: (2017)

Enhancing the Anti-tumor Potency of a Novel Siglec-15 Antibody by Engineering its Fc-mediated Effector Functions
por: Ding, Huandi, et al.
Publicado: (2023)

Structural insights showing how arginine is able to be glycosylated by pathogenic effector proteins
por: Park, Jun Bae, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1nt0t94din51sem7q5dkut9ums